Tenax Therapeutics (TENX) EBITDA Margin (2010 - 2022)
Tenax Therapeutics (TENX) recorded EBITDA Margin of -29762.21% in FY2015, down 19404.79 percentage points from -10357.42% in FY2014.
Powered by 
Analysis
Tenax Therapeutics (TENX) EBITDA Margin (2010 - 2022) Analysis & Trends
Starting with FY2011, Tenax Therapeutics' EBITDA Margin history includes 5 years.
- Annual EBITDA Margin has a four-year change of -40302.11 percentage points (FY2011 to FY2015).
- The FY2015 figure is the lowest annual EBITDA Margin in data going back to FY2011.
- Per Business Quant data, TENX's EBITDA Margin was -10357.42% in FY2014 (-9934.20 pp), -423.22% in FY2013 (+1779.62 pp), -2202.84% in FY2012 (-12742.75 pp) and 10539.90% in FY2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | Tenax Therapeutics | 82.92 Mn | -350.75 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 791,935.75% |
| Jun 30, 2022 | 196,541.17% |
| Mar 31, 2022 | 107,170.70% |
| Jun 30, 2021 | 592,310.12% |
| Mar 31, 2021 | 3,879,263.46% |
| Dec 31, 2020 | 468,537.81% |
| Sep 30, 2020 | 369,510.00% |
| Jun 30, 2020 | 535,089.16% |
| Apr 30, 2013 | -661.55% |
| Jan 31, 2013 | -699.02% |
| Oct 31, 2012 | -125.50% |
| Jul 31, 2012 | -602.12% |
| Apr 30, 2012 | -1,909.76% |
| Jan 31, 2012 | -1,231.94% |
| Oct 31, 2011 | -2,129.53% |
| Jul 31, 2011 | -9,395.75% |
| Apr 30, 2011 | 6,278.37% |
| Jan 31, 2011 | 10,602.41% |
| Oct 31, 2010 | 7,794.14% |
API Access
Tenax Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TENX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TENX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TENX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();